Cargando…
Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
Endothelial dysfunction is recognized as one of the leading factors in the pathogenesis of diseases of the central nervous system of various etiologies. Numerous studies have shown the role of hyperhomocysteinemia in the development of endothelial dysfunction and the prothrombogenic state. The most...
Autores principales: | Dubchenko, Ekaterina, Ivanov, Alexander, Spirina, Natalia, Smirnova, Nina, Melnikov, Mikhail, Boyko, Alexey, Gusev, Evgeniy, Kubatiev, Aslan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564574/ https://www.ncbi.nlm.nih.gov/pubmed/32947812 http://dx.doi.org/10.3390/brainsci10090637 |
Ejemplares similares
-
Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
por: Melnikov, Mikhail, et al.
Publicado: (2021) -
Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration
por: Kountouras, Jannis, et al.
Publicado: (2023) -
Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies
por: Boyko, Alexey, et al.
Publicado: (2020) -
Hyperhomocysteinemia: Focus on Endothelial Damage as a Cause of Erectile Dysfunction
por: Salvio, Gianmaria, et al.
Publicado: (2021) -
Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy
por: Melnikov, Mikhail, et al.
Publicado: (2022)